![Christopher Starr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Starr
Founder at
MONOPAR THERAPEUTICS INC.
Net worth: 979 047 $ as of 2026-05-30
Profile
Christopher M.
Starr was the founder of Horizon Pharmaceutical LLC, founded in 2009, serving as Independent Director from 2015 to 2016.
Dr. Starr is the founder of Monopar Therapeutics, Inc., founded in 2014, serving as Executive Chairman since 2014.
Dr. Starr was the founder of BioMarin Pharmaceutical, Inc., founded in 1997, serving as Chief Scientific Officer & VP-R&D.
Dr. Starr was the founder of Raptor Pharmaceuticals Corp., founded in 2005, serving as Director from 2014 to 2016.
Current jobs include Chief Executive Officer at Raptor Discoveries, Inc. since 2005, Chairman at Thiogenesis Therapeutics, Inc., and Chairman at Thiogenesis Therapeutics Corp.
since 2022.
Former jobs include Executive Chairman at Glycomine, Inc. in 2016, Vice President-Research & Development at Glyko, Inc. from 1991 to 1998, and Associate at The National Research Council and National Institutes of Health.
Education includes a doctorate from SUNY Upstate Medical University and an undergraduate degree from Syracuse University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 15,053 ( 0.22% ) | 979 047 $ | 2026-05-30 |
Christopher Starr active positions
| Companies | Position | Start |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Founder | 2014-11-30 |
| THIOGENESIS THERAPEUTICS, CORP. | Chairman | 2022-03-30 |
Raptor Discoveries, Inc. | Chief Executive Officer | 2005-09-07 |
Former positions of Christopher Starr
| Companies | Position | End |
|---|---|---|
| RAPTOR PHARMACEUTICAL CORP | Founder | 2016-10-24 |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Founder | 2016-09-30 |
| BIOMARIN PHARMACEUTICAL INC. | Founder | 2005-12-31 |
Glyko, Inc.
 Glyko, Inc. Medical SpecialtiesHealth Technology Discovers, develops, and commercializes carbohydrate enzyme therapeutics | Chief Tech/Sci/R&D Officer | 1997-12-31 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
Training of Christopher Starr
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
39
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Glyko, Inc.
Glyko, Inc. Medical SpecialtiesHealth Technology Discovers, develops, and commercializes carbohydrate enzyme therapeutics | Health Technology |
SUNY Upstate Medical University
 SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
The National Research Council
 The National Research Council Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy consulting and advice | Commercial Services |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Raptor Discoveries, Inc. | |
Monopar Therapeutics, Inc.
 Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Develops replacement therapies for rare genetic diseases | Health Technology |
Thiogenesis Therapeutics Corp.
 Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
- Stock Market
- Insiders
- Christopher Starr
